Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
QNB CORPQNB Corp. Reports Increased Net Income and Plans Acquisition of The Victory Bancorp
ACORN ENERGY, INC.Acorn Energy Reports 22% Revenue Growth for Nine Months Ending September 30, 2025
Solo Brands, Inc.Solo Brands Reports 43.7% Decline in Q3 2025 Net Sales, Net Loss of $22.9 Million
National Vision Holdings, Inc.National Vision Holdings Reports 7.9% Revenue Growth to $487.3 Million in Q3 2025
Rallybio CorpRallybio Corporation Reports $16M Net Income in Q3 2025, Driven by Joint Venture Sale
Leatt CorpLeatt Corporation Reports 18% Revenue Growth to $14.34 Million in Latest Quarter
GOLDEN ENTERTAINMENT, INC.Golden Entertainment Reports 4% Revenue Decline in Q3 2025
MBX Biosciences, Inc.MBX Biosciences Reports $21.6 Million Net Loss in Latest Quarter, Increases R&D Spending
SANGAMO THERAPEUTICS, INCSangamo Therapeutics Reports 98.8% Revenue Decline and Financial Challenges
International Seaways, Inc.International Seaways Reports Decline in Q3 2025 Financial Performance
Replimune Group, Inc.Replimune Group Reports $83.1 Million Net Loss in Q2 Fiscal 2025
PATRICK INDUSTRIES INCPatrick Industries Reports 6% Net Sales Increase to $975.6 Million in Q3 2025
RAPT Therapeutics, Inc.RAPT Therapeutics Reports $17.6 Million Net Loss in Q3 2025, Sees Improvement in Financial Position
BlackRock TCP Capital Corp.BlackRock TCP Capital Corp. Reports Q3 Financial Results with Decrease in Net Investment Income
Mural Oncology plcMural Oncology Reports $3.7 Million Net Loss and Significant Organizational Changes
UroGen Pharma Ltd.UroGen Pharma Reports $27.5M Revenue in Q3 2025, Net Loss Increases to $33.3M
SOUTH PLAINS FINANCIAL, INC.South Plains Financial Reports 45.5% Increase in Net Income for Q3 2025
SILENCE THERAPEUTICS PLCSilence Therapeutics Reports Significant Revenue Decline and Increased Net Losses for Q3 2025
Backblaze, Inc.Backblaze Reports 14% Revenue Growth to $37.2 Million in Q3 2025
NOVAVAX INCNovavax Reports $70.4 Million Revenue in Q3 2025, Down 16.6% Year-Over-Year
Lantheus Holdings, Inc.Lantheus Holdings Reports Q3 2025 Revenue of $384M, Net Income Declines 78.8%
Safehold Inc.Safehold Inc. Reports Revenue Growth to $96.2 Million in Q3 2025
NEXTNAV INC.NextNav Inc. Reports Q3 2025 Revenue Decline and Increased Operating Losses
TerrAscend Corp.TerrAscend Reports Q3 2025 Financial Results with $65.1M Revenue and Net Loss Improvement
COLLEGIUM PHARMACEUTICAL, INCCollegium Pharmaceutical Reports 31.4% Revenue Growth to $209.4 Million in Latest Quarter